diagnosis monitoring News
-
Congressman Mike Michaud (D-ME) invites West Wireless Health Institute to testify before Veterans` Affairs Health Subcommittee
The U.S. House Committee on Veterans" Affairs Subcommittee on Health, led by Chairman Mike Michaud (D-ME) and Ranking Member Henry Brown (R-SC), has invited Joseph M. Smith, MD, PhD, Chief Medical and Science Officer of the West Wireless Health Institute, to testify at a Subcommittee hearing, Thursday, June 24, examining the use of innovative wireless health technologies to help redress barriers ...
-
DiamiR Receives USPTO Notice of Allowance For Key Patent Covering the Use of Circulating Brain-Enriched microRNA Biomarkers for Monitoring of Brain Aging; Provides Update on Its Patent Portfolio
DiamiR, a developer of innovative blood-based diagnostic tests for neurodegenerative and other diseases, today announced that it has received a notice of allowance from the United States Patent & Trademark Office (USPTO) for U.S. Patent Application No. 16/044,279 entitled "miRNA-based methods for detecting and monitoring aging." The patent covers the use of methods developed by DiamiR based ...
By DiamiR
-
Thermo Fisher Scientific Launches New MAS Omni Infectious Disease Quality Controls
Thermo Fisher Scientific, the world leader in serving science, today announced the availability of the Thermo Scientific MAS Omni Infectious Disease quality control sets for monitoring serological assays for analytes such as HIV 1&2, Hepatitis B & C virus, Syphilis and HTLV I/II. Serology testing for infectious diseases continues to be on the rise and newer instrument platforms are ...
-
Focal Healthcare and CIMTEC Sign Licensing Agreement for a Suite of 3D Ultrasound AI-Based Technologies
The collaboration allows Focal Healthcare to develop a smart 3D ultrasound imaging platform for point of care use. TORONTO, CANADA – Focal Healthcare, known globally as a leading innovator of image-guided prostate cancer technology, is diversifying their product line by developing an AI-based 3D ultrasound imaging platform. Focal Healthcare has licensed patents from the Centre for Imaging ...
-
DiamiR Receives USPTO Notice of Allowance For Key Patent Covering the Use of microRNA Biomarkers from Bodily Fluids for Diagnosis and Monitoring of Rett Syndrome and Other Neurodevelopmental Diseases
DiamiR, a developer of innovative blood-based diagnostic tests for brain health and other diseases, today announced that it has received a notice of allowance from the United States Patent & Trademark Office (USPTO) for U.S. Patent Application No. 16/028,206 entitled "Methods of using miRNA from bodily fluids for diagnosis and monitoring of neurodevelopmental disorders." The patent covers the ...
By DiamiR
-
NanoPin Technologies Announces a Research Collaboration Agreement to Advance a Rapid Blood-based Test for Tuberculosis and Infectious Diseases
NanoPin Technologies, Inc., whose mission is to develop advanced diagnostics to improve the lives of millions of individuals affected by infectious disease, announces the formation of a collaboration with Thermo Fisher Scientific to refine the liquid chromatography mass spectrometry (LCMS)-based workflow to allow robust and highly sensitive clinical application of NanoPin’s proprietary ...
-
Qynapse to Present New Evidence on the Value of QyScore for the Diagnosis and Monitoring of Multiple Sclerosis at ACTRIMS Forum 2022
BOSTON, MA, February 14, 2022, PRNewswire – Qynapse Inc., a medical technology company commercializing an AI-powered neuroimaging software platform for central nervous system (CNS) disorders, is pleased to present 2 posters at the annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2022, on February 24-26, in West Palm Beach, FL. The posters ...
By Qynapse
-
Nuubo Receives US FDA 510 (k) Clearance for the Nuubo System
Spanish medical device innovator Nuubo (https://www.nuubo.com) today announced it has received United States Food and Drug Administration (FDA) 510 (k) clearance to market its Nuubo System, a disruptive wireless, textile-based ambulatory electrocardiogram (aECG) technology that enables mid and long-term monitoring for cardiac arrhythmia ...
By Nuubo
-
OnLume Surgical Participates in Clinical Trial Combining Fluorescence-Guided Surgery Imaging Device with Alume’s Novel Nerve-Targeting Agent
OnLume Inc., a Madison, Wisconsin-based medical imaging company with unique technology for improving surgical precision in the operating room, has announced the start of participation in a clinical trial combining its fluorescence-guided surgery (FGS) imaging device with a novel nerve-targeting agent. OnLume has unique FGS imaging technology to illuminate critical anatomy in real time during ...
By OnLume Inc.
-
Villa Beretta Rehabilitation Center - BioXtreme Post Marketing Evaluation Site
Villa Beretta Rehabilitation Center and BioXtreme are proud to announce that they have agreed to conduct a joint evaluation project in the hospital’s facility in Costa-Masnaga, Italy. BioXtreme has developed a ground-breaking robotic device for motor-learning, based on innovative error enhancement technology for upper limb rehabilitation from stroke and other neurological injuries. Villa ...
-
CD Genomics: The Biomedical Bioinformatics Platform Unveils Biomarker and Target Discovery Data Analysis Service
The Biomedical Bioinformatics Platform belongs to CD Genomics and has a good reputation for assisting researchers with data analysis challenges, including NGS data processing, analysis, interpretation, and general genomic data analysis, as well as data mining, statistical modeling, data integration, information science, database construction, and management. Recently, the company announced the ...
By CD Genomics
-
Subtle Medical and Bayer Collaborate to Advance Deep Learning Research to Harness the Power of AI in Medical Imaging
Subtle Medical, a leading healthcare technology company, and Bayer, a leading life science company with extensive expertise from diagnosis to care, announced today a collaboration to explore opportunities to utilize AI (artificial intelligence) to aid in image acquisition in radiology. The companies will investigate the potential of Subtle Medical’s state-of-the-art AI algorithm, ...
-
Alume Biosciences Granted FDA Fast Track Designation of ALM-488 for Surgical Nerve Visualization
Alume Biosciences, Inc., a clinical stage biotechnology company developing nerve-targeted pharmaceuticals for surgical and therapeutic use, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for its lead compound ALM-488. ALM-488 is an investigational fluorescently labelled nerve targeting pharmaceutical being developed as an adjunct for the ...
-
CardiacSense Medical Grade Watch receives CE Mark for continuous detection of Atrial Fibrillation
CardiacSense – a digital health company that developed and clinically verified a medical grade watch capable of detecting and remotely monitoring Atrial Fibrillation (A-Fib) and Heart Rate Variability (HRV) announced that it received the CE Mark for marketing & sales of the device in the European Union. The indications certified include “detection of Atrial Fibrillation ...
By CardiacSense
-
It All Starts With Patient Safety at Medovate
When Medovate was spun out of the National Health Service (NHS) in 2017, one of the key priorities was to ensure that each medical device the company developed added real value to patient safety. The company mission is to “improve patient care and safety by supplying innovative Medtech solutions inspired by clinicians and developed in partnership with the NHS.” Through a unique ...
By Medovate
-
Revolutionary non-invasive technology supporting early diagnosis of Parkinson’s disease showcased at MEDICA 2021
Manus Neurodynamica Limited (“Manus”), who develop and market products and technologies for neuromotor assessment, will be joining the ABHI UK Pavilion at MEDICA 2021 (15 – 18 November 2021) to launch their revolutionary non-invasive technology that supports an earlier and more accurate diagnosis of dementias and cognitive impairment. The NeuroMotor Pen (NMP) is a unique, ...
-
Edinburgh Molecular Imaging and Mauna Kea Technologies Announce Clinical Molecular Imaging Collaboration
Edinburgh Molecular Imaging Ltd (EM Imaging) and Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) today announced a clinical research collaboration to study the potential of combining EM Imaging’s in vivo optical imaging agents and Mauna Kea’s confocal laser endomicroscopy platform to diagnose cancer. The combination of novel molecular imaging agents and advanced visualisation ...
-
New Expanded Analytical Instrument Portfolio of U.S. FDA Class I Medical Devices for Clinical Diagnostic Laboratories
Thermo Fisher Scientific has expanded its portfolio of analytical instruments for clinical diagnostic laboratories with the addition of three systems now listed as Class I medical devices with the United States Food and Drug Administration (U.S. FDA). The portfolio enables clinical diagnostic laboratories to leverage a comprehensive platform for developing sensitive and reliable laboratory ...
-
Arterys Partners With Combinostics to Accelerate Accurate and Consistent Evaluations of Patients With Neurodegenerative Disease and Multiple Sclerosis
SAN FRANCISCO, November 26, 2021 (Newswire.com) - Arterys, the world's leading vendor neutral AI platform, today announced its partnership with Combinostics to make their AI imaging solution, cNeuro® available on the Arterys Platform. This partnership enables Arterys to have the most comprehensive Neuro AI suite on the market covering a broad set of applications in neuroradiology. Arterys ...
By Arterys Inc.
-
US FDA Allows Trial to Proceed for Alume Biosciences` Nerve Imaging Candidate
Alume Biosciences, Inc., a biotechnology company developing nerve-targeted pharmaceuticals for surgical and therapeutic use, today announced that it has received a "Study May Proceed" letter from the US Food and Drug Administration (FDA) related to its recently filed Investigational New Drug (IND) application for the use of ALM-488 in head and neck surgery. ALM-488 is an intravenously ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you